Evidence map›Paper›PMID 35153815›Full record

ReviewFrontiers in physiology2021

The Potential Relationship Between Environmental Endocrine Disruptor Exposure and the Development of Endometriosis and Adenomyosis.

Victoria R Stephens, Jelonia T Rumph, Sharareh Ameli, Kaylon L Bruner-Tran, Kevin G Osteen

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. The interplay between endometriosis and obesity.Trends in endocrinology and metabolism: TEM · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Endometriosis and adenomyosis unveiled through single-cell glasses.American journal of obstetrics and gynecology · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Victoria R StephensDepartment of Obstetrics and Gynecology, Women's Reproductive Health Research Center, Vanderbilt University School of Medicine, Nashville, TN, United States.
Jelonia T RumphDepartment of Obstetrics and Gynecology, Women's Reproductive Health Research Center, Vanderbilt University School of Medicine, Nashville, TN, United States.
Sharareh AmeliDepartment of Obstetrics and Gynecology, Women's Reproductive Health Research Center, Vanderbilt University School of Medicine, Nashville, TN, United States.
Kaylon L Bruner-TranDepartment of Obstetrics and Gynecology, Women's Reproductive Health Research Center, Vanderbilt University School of Medicine, Nashville, TN, United States.
Kevin G OsteenDepartment of Obstetrics and Gynecology, Women's Reproductive Health Research Center, Vanderbilt University School of Medicine, Nashville, TN, United States.
Vanderbilt University · USVA Tennessee Valley Healthcare System · US

Funding

Role of cancer-associated mutations in endometriosisR01HD096147 · NICHD · JOHNS HOPKINS UNIVERSITY · PI SEGARS, JAMES H., SHIH, IE-MING · 2019 to 2023
$3.4M
NICHD NIH HHS R01 HD096147
6 · The paper itself

Abstract

Women with endometriosis, the growth of endometrial glands and stroma outside the uterus, commonly also exhibit adenomyosis, the growth of endometrial tissues within the uterine muscle. Each disease is associated with functional alterations in the eutopic endometrium frequently leading to pain, reduced fertility, and an increased risk of adverse pregnancy outcomes. Although the precise etiology of either disease is poorly understood, evidence suggests that the presence of endometriosis may be a contributing factor to the subsequent development of adenomyosis as a consequence of an altered, systemic inflammatory response. Herein, we will discuss the potential role of exposure to environmental toxicants with endocrine disrupting capabilities in the pathogenesis of both endometriosis and adenomyosis. Numerous epidemiology and experimental studies support a role for environmental endocrine disrupting chemicals (EDCs) in the development of endometriosis; however, only a few studies have examined the potential relationship between toxicant exposures and the risk of adenomyosis. Nevertheless, since women with endometriosis are also frequently found to have adenomyosis, discussion of EDC exposure and development of each of these diseases is relevant. We will discuss the potential mechanisms by which EDCs may act to promote the co-development of endometriosis and adenomyosis. Understanding the disease-promoting mechanisms of environmental toxicants related to endometriosis and adenomyosis is paramount to designing more effective treatment(s) and preventative strategies.

Indexed as

adenomyosisendocrine disrupting chemical (EDC)endometriosisenvironmental toxicantsinflammation

Identifiers

PMID35153815
PMCPMC8832054
OpenAlexW4210415655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.